Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides
about
Structural basis of peptide recognition by the angiotensin-1 converting enzyme homologue AnCE from Drosophila melanogasterA modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzymeHuman ACE and bradykinin B2 receptors form a complex at the plasma membraneAngiotensin-I-converting enzyme and its relativesHuman physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat.The kallikrein-kinin system in diabetic nephropathyThe kallikrein-kinin system and oxidative stressA crucial role in fertility for the oyster angiotensin-converting enzyme orthologue CgACEThe N Domain of Human Angiotensin-I-converting Enzyme: THE ROLE OF N-GLYCOSYLATION AND THE CRYSTAL STRUCTURE IN COMPLEX WITH AN N DOMAIN-SPECIFIC PHOSPHINIC INHIBITOR, RXP407Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptideMolecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptidesFragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitorsCrystal structures of highly specific phosphinic tripeptide enantiomers in complex with the angiotensin-I converting enzymeInterkingdom Pharmacology of Angiotensin-I Converting Enzyme Inhibitor Phosphonates Produced by ActinomycetesAngiotensin I-converting enzyme Gln1069Arg mutation impairs trafficking to the cell surface resulting in selective denaturation of the C-domainRXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites.Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function.N- versus C-domain selectivity of catalytic inactivation of human angiotensin converting enzyme by lisinopril-coupled transition metal chelatesImpaired proteostasis contributes to renal tubular dysgenesis.Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism and ACE inhibitor-related cough: a meta-analysis.In vivo bradykinin B2 receptor activation reduces renal fibrosis.A novel angiotensin I-converting enzyme mutation (S333W) impairs N-domain enzymatic cleavage of the anti-fibrotic peptide, AcSDKP.Naturally occurring active N-domain of human angiotensin I-converting enzyme.Nontraditional roles of angiotensin-converting enzyme.Genetic Variants of Angiotensin-Converting Enzyme Are Linked to Autism: A Case-Control Study.Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme.Targeted catalytic inactivation of angiotensin converting enzyme by lisinopril-coupled transition-metal chelatesThe kallikrein-kinin system in health and in diseases of the kidney.Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme.Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-prolineThe critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice.Absence of cell surface expression of human ACE leads to perinatal death.Drosophila melanogaster angiotensin I-converting enzyme expressed in Pichia pastoris resembles the C domain of the mammalian homologue and does not require glycosylation for secretion and enzymic activity.Kinetic probes for inter-domain co-operation in human somatic angiotensin-converting enzyme.ACE phenotyping in human heart.The endopeptidase activity and the activation by Cl- of angiotensin-converting enzyme is evolutionarily conserved: purification and properties of an an angiotensin-converting enzyme from the housefly, Musca domestica.A novel peptide-processing activity of insect peptidyl-dipeptidase A (angiotensin I-converting enzyme): the hydrolysis of lysyl-arginine and arginyl-arginine from the C-terminus of an insect prohormone peptide.Angiotensin-converting enzyme defines matrikine-regulated inflammation and fibrosis.Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.N-domain of angiotensin-converting enzyme hydrolyzes human and rat amyloid-β(1-16) peptides as arginine specific endopeptidase potentially enhancing risk of Alzheimer's disease.
P2860
Q24301320-8FF3A9EF-989D-4F25-A1A6-A4457D581E1EQ24306614-3C91D7C2-55FD-4AEE-9727-C5496E6BB6AEQ24310586-15CFC52D-7F81-44A9-AFA6-371EEDE717CDQ24796698-6E426FFC-7334-4D75-BC51-82FF1E1A5E68Q25257437-9994B709-DBD8-499F-B5AD-88F0620AD838Q26827473-64BB6EDB-07D3-47CF-AD08-66515F516362Q27000456-27F9C406-1D13-409B-A65D-D932E39B9DA7Q27312144-64E08C4D-2911-4917-903C-40F46697A1D3Q27664390-E57577DC-70F4-4CFA-987E-F81D28F832EFQ27667064-C6E7FA41-747E-4424-B9FD-05B210F92073Q27674442-75564C5A-2AF1-4F3C-88C0-0874A2538DBEQ27679900-E1673AB2-897B-4897-9543-4A1DACA7A390Q27680712-98E725E0-B779-4ACF-BD1B-DE4841611039Q27684235-AEDC8BCB-F980-44DA-8D9C-07AEFBB1A7B4Q28473818-7540C4CF-E01D-4554-98E5-7029D2DFCA62Q30670251-B3ED71AA-76A1-4743-9188-D7CC10157429Q33623829-AB03D2CC-6C57-4605-8B5D-53730121E4AFQ33737152-C09655D5-AFB5-4481-A2F8-1F145A6AC034Q33939731-920A6CD0-A99E-4A73-AA6C-3003038BB3B1Q34313772-2DB3E293-5D3D-4FE2-914D-CD12D91C39EBQ34795075-D7AE689E-D9AE-465B-8D13-C10EA0CD6A93Q35088357-A615F102-49C2-4DF8-8813-992853C55499Q35665330-76139E83-5125-4E17-B941-1A835F8B5F65Q35836666-D513DBBA-379B-449D-93D0-8D5A488CDF43Q35991106-2E90239B-1AF1-400A-A5C9-0316D942A15DQ36099917-C8D4FF86-7501-4B87-B53F-0237CF932A25Q36106851-3E6B2BD6-0C92-4CA3-9B47-7A9490389F19Q37070150-F7BA634A-BE6A-4A6A-A6EA-33BE27FEAE5DQ37107046-58E0407A-A643-4FDA-86E6-ED75F0CD6C42Q37351830-B980D892-1A47-4AC6-8642-D9BD4782E65DQ37367283-56F4484E-17DA-4F1D-9A19-3D26226168F0Q37593031-343E9463-CE48-4F4C-930F-A5D3DED4AE1EQ38354068-40111ED6-7B50-45E4-ACB8-B47BD6F57FC9Q39499465-98BDDBEF-94C1-4434-BC13-6C8F34CB667CQ41235667-F74B16D8-B8C1-49FB-B329-A94B4E5AA2B0Q42549805-AD3006D7-CC78-48B4-B110-91125AA6F534Q42939489-8019D674-4459-4C78-8D83-FF432436CA78Q46248584-22961D4B-A441-4BF1-8782-95BC7FCD26A2Q47720411-DE9E0BBA-FC61-4F67-B897-7BA15D4768A0Q50101151-79777CD4-98A8-4021-899E-91E72B89DC19
P2860
Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides
description
1993 nî lūn-bûn
@nan
1993 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Differences in the properties ...... nin and other natural peptides
@ast
Differences in the properties ...... nin and other natural peptides
@en
Differences in the properties ...... nin and other natural peptides
@en-gb
Differences in the properties ...... nin and other natural peptides
@nl
type
label
Differences in the properties ...... nin and other natural peptides
@ast
Differences in the properties ...... nin and other natural peptides
@en
Differences in the properties ...... nin and other natural peptides
@en-gb
Differences in the properties ...... nin and other natural peptides
@nl
prefLabel
Differences in the properties ...... nin and other natural peptides
@ast
Differences in the properties ...... nin and other natural peptides
@en
Differences in the properties ...... nin and other natural peptides
@en-gb
Differences in the properties ...... nin and other natural peptides
@nl
P2093
P3181
P1476
Differences in the properties ...... nin and other natural peptides
@en
P2093
P304
P3181
P407
P577
1993-05-05T00:00:00Z